Drugs / Destin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02080247 Comparator | Dec 2012 → Apr 2014 | irritant dermatitis | University of the Philippines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Destin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02080247 ↗ |
| Known as | Destin Maximum Strength 40% Zinc Oxide Diaper Rash Paste | “Patients will receive treatment with Destin Maximum Strength 40% Zinc Oxide Diaper Rash Paste (Destin) for 6 days as part of a structured skin care regimen.” NCT02080247 ↗ |
| Route | Topical | “applied on the affected area” NCT02080247 ↗ |